Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | STK10 | O94804 | 1/20 | 0.32 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | NAT1 | P18440 | 2/20 | 0.31 |
| ▸ | KCNK18 | Q7Z418 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23040798 | 0.79 | GAA (0.44) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL34463543 | 0.78 | GAA (0.36) | TDO2GAAMAPTKDM4ES1PR1 | |
| SCHEMBL34463519 | 0.78 | GAA (0.37) | TDO2GAAMAPTKDM4ES1PR1 | |
| SCHEMBL34463544 | 0.78 | NAT1 (0.37) | GAAMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL29905111 | 0.74 | MAPT (0.42) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL22188160 | 0.74 | MAPT (0.42) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL23610039 | 0.73 | ALDH1A1 (0.50) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL29119794 | 0.71 | GAA (0.46) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL15954330 | 0.71 | GAA (0.46) | GAAMAPTKDM4ES1PR1RXRA | |
| SCHEMBL25565289 | 0.71 | MAPT (0.40) | GAAMAPTKDM4ES1PR1RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260107678-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107678-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, NR1H2, LDLR | TDO2 1915/4885GAA 3547/4885MAPT 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.